✦ LIBER ✦

Pharmacokinetics of etoposide in cancer patients treated with high-dose etoposide and with dexrazoxane (ICRF-187) as a rescue agent

✍ Scribed by PatriciaE. Schroeder; KennethFrancis Hofland; PeterBuhl Jensen; Maxwell Sehested; SeppoW. Langer; BrianB. Hasinoff

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metabolism of dexrazoxane (ICRF-187) use

✍ Patricia E. Schroeder; Peter Buhl Jensen; Maxwell Sehested; Kenneth Francis Hofl 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 278 KB

High-dose doxorubicin, etoposide, and cy

✍ George Somlo; James H. Doroshow; Stephen J. Forman; Lucille A. Leong; Kim A. Mar 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 780 KB

Comparative open, randomized, cross-over

✍ H. Rosing; W. W. Ten Bokkel Huinink; R. van Gijn; R. F. M. Rombouts; A. Bult; J. 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 795 KB

A randomized trial of chemotherapy with

✍ J.-P. Glossmann; A. Josting; B. Pfistner; U. Paulus; A. Engert; German Hodgkin's 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 90 KB